Supply and Delivery of Various Medical Supplies

SOL #: 19RP3826Q0053Award Notice

Overview

Buyer

State
State, Department Of
U.S. EMBASSY MANILA
WASHINGTON, DC, 20520, United States

Place of Performance

Pasay, PH-PAS, Philippines

NAICS

Surgical and Medical Instrument Manufacturing (339112)

PSC

Medical And Surgical Instruments, Equipment, And Supplies (6515)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 12, 2026
2
Last Updated
Apr 1, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The U.S. Embassy Manila has awarded PHOENIX CONTRACTING LLC a contract (19RP3826P0656) for the Supply and Delivery of Various Medical Supplies under solicitation 19RP3826Q0053. The contract, valued at $74,820.00 USD, was awarded on April 1, 2026, for performance in Pasay, Philippines.

Scope of Work

This contract covers the supply and delivery of a comprehensive range of medical and dental supplies, including CPR manikins, first aid kits, various medications, diagnostic tools, surgical supplies, dental equipment, and general supplies. Deliveries are scheduled across five distinct batches, with the final batch due by April 30, 2026, to the Embassy Seafront Compound Warehouse in Pasay, Philippines.

Contract Details

  • Contract Awardee: PHOENIX CONTRACTING LLC
  • Contract Number: 19RP3826P0656
  • Solicitation Number: 19RP3826Q0053
  • Award Amount: $74,820.00 USD
  • Award Date: April 1, 2026
  • Place of Performance: Pasay, Philippines
  • Contracting Office: U.S. Embassy Manila, Department of State

Key Requirements & Clarifications

The original Request for Quotation (RFQ) required compliance with specific FAR clauses (e.g., 52.204-24, -25, -26, 52.212-3, -4) and proof of past performance. Subsequent clarifications indicated that "Made in USA" requirements, FDA DSCSA compliance, and U.S. pharmaceutical licenses were not mandatory for pharmaceuticals, as they were intended for local medical missions supporting Philippine nationals. Generic or equivalent products were acceptable, and product origin was not a disqualifying factor. Delivery dates were firm and tied to mission schedules, and TAA compliance was not required due to the value being below the threshold.

Set-Aside

No specific set-aside was designated for this opportunity.

Contact Information

People

Points of Contact

Files

Files

Download
Download
Download
Download
Download
Download
Download

Versions

Version 5Viewing
Award Notice
Posted: Apr 1, 2026
Version 4
Solicitation
Posted: Mar 26, 2026
View
Version 3
Solicitation
Posted: Mar 23, 2026
View
Version 2
Solicitation
Posted: Mar 13, 2026
View
Version 1
Solicitation
Posted: Mar 12, 2026
View